Agilent/Dako

Actin (Smooth Muscle)/ACTA2

#M085129-2 · immunohistochemistry

14
Citing papers
250
Combined citations
Supplier page Find this product

Research areas

Axon Guidance and Neuronal Signaling5Angiogenesis and VEGF in Cancer5Esophageal Cancer Research and Treatment4Signaling Pathways in Disease3Wnt/β-catenin signaling in development and cancer2Cancer Cells and Metastasis2Epigenetics and DNA Methylation2Cancer Immunotherapy and Biomarkers1

Papers citing this product

1
Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinoma
The Journal of Pathology·2014·182 cit.·DOI
2
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
Cell Reports Medicine·2022·24 cit.·DOI
3
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
F1000Research·2020·16 cit.·DOI
4
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
F1000Research·2020·15 cit.·DOI
5
P2X7 Receptor Blockade Protects Against Acrolein-Induced Bladder Damage: A Potential New Therapeutic Approach for the Treatment of Bladder Inflammatory Diseases
Frontiers in Pharmacology·2021·4 cit.·DOI
6
Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts
Scientific Reports·2017·4 cit.·DOI
7
Modulation of the tumour promoting functions of cancer associated fibroblasts by phosphodiesterase type 5 inhibition increases the efficacy of chemotherapy in human preclinical models of esophageal adenocarcinoma
bioRxiv (Cold Spring Harbor Laboratory)·2020·2 cit.·DOI
8
Targetable fibroblast phenotypes and EMT malignant cell states cooperate to promote tumor progression in esophageal adenocarcinoma
Research Square·2023·2 cit.·DOI
9
Cancer-associated fibroblasts are associated with neo-adjuvant treatment response in oesophageal adenocarcinoma
British Journal of Cancer·2025·1 cit.·DOI
10
Referee report. For: Host deficiency in ephrin-A1 inhibits breast cancer metastasis [version 1; peer review: 2 approved]
Faculty of 1000 Research Ltd·2020·DOI

Also available from other vendors

This target has 226 citing papers across all vendors combined

VendorProductEvidencePricePapers
Agilent/DakoActin (Smooth Muscle) (Dako Omnis)———
Agilent/DakoMonoclonal Mouse Anti Human Smooth Muscle Actin——100
Agilent/DakoAlpha-Smooth Muscle Actin68—30
Agilent/DakoFLEX Monoclonal Mouse Anti-Human Smooth Muscle Actin, Clone 1A4, Ready-to-Use (Link)——21
R&D SystemsHuman/Mouse/Rat alpha-Smooth Muscle Actin Antibody——61
R&D SystemsHuman alpha-Smooth Muscle Actin PE-conjugated Antibody———
Thermo Fisher ScientificSmooth Muscle Actin Monoclonal Antibody (1A4)———

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.